NitroMed, Inc.

NitroMed, Inc.

NitroMed, Inc.

Overview
Date Founded

1987

Headquarters

6000 Fairview Road,Suite 610,Charlotte, NC 28210

Type of Company

Private

Industries

Pharmaceuticals
Medical Support Services
Biotechnology

Company Description

NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Charlotte. NC.

Contact Data
Trying to get in touch with decision makers at NitroMed, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
The New York Times - Biographical Materials
January 1, 2013
Race and Medicine
Executives & Employees

Co-Founder

President

Vice President

Senior Scientist

Board of Directors

Chief Physician at The Brigham & Women's Hospital, Inc.

Managing Partner at Rho Capital Partners, Inc.

Former Chief Executive Officer at NitroMed, Inc.

Paths to NitroMed, Inc.
Potential Connections via
Relationship Science
You
NitroMed, Inc.
Recent Transactions
Details Hidden

Arbor Pharmaceuticals LLC, JW Asset Management LLC/Private Equity purchase NitroMed, Inc. from Deerfield Management Co. LP (Private Equity)

Details Hidden

Deerfield Management Company LP purchases NitroMed, Inc.

Details Hidden

NitroMed, Inc. issued Common Stock

Transaction Advisors
Underwriter

Advised onNitroMed, Inc. issued Common Stock

Underwriter

Advised onNitroMed, Inc. issued Common Stock

Underwriter

Advised onNitroMed, Inc. issued Common Stock

Legal Advisor

Advised onNitroMed, Inc. issued Common Stock

Advisors & Consultants
Legal Advisor

Partner at Wilmer Cutler Pickering Hale and Dorr LLP

Legal Advisor

Secretary & Director at Oxfam America, Inc.

Investors
Details Hidden

Deerfield Management Co. LP (Private Equity) invests in a broad range of industries. It provides financing for buyout transactions to private and public companies located in the U.S.

Details Hidden

MSVP invests predominantly in US based companies with opportunistic investing internationally in late-stage growth investments. The firm target companies operating in the fields technology, health care, consumer and digital media. They act as lead investor, typically with board seat and holds minority & shared-control.

Details Hidden

Rho Ventures focuses on investments in the information technology, communications, new media, healthcare and energy technology sectors. The firm invests across all stages of a company's development from seed to growth equity rounds. Rho Ventures usually acts as lead investor. The firm looks for companies with: (1) outstanding entrepreneurial management teams capable of building exceptional companies (2) growing markets with the potential to produce revenue greater than $500 million (3) market-leading positions with a high level of product/service differentiation (4) well-defined customer value propositions (5) high barriers to competitive entry and (6) scalable and well-defined business models

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by NitroMed, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of NitroMed, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and NitroMed, Inc..